Dr. Mélèze Hocini, MD, PhD is professor at Bordeaux University Hospital, Department of Cardiac arrhythmias center in Bordeaux, France. I have more than 20 years of experience in catheter ablation procedures, including atrial fibrillation ablation and ablation of ventricular fibrillation (VF). My research interests focus on the mechanisms of atrial rhythm disorders and their treatment, as well as mapping and treatment of ventricular fibrillation and evaluation of patients at risk of sudden cardiac death.

After graduating in medicine in 1996, I went on to specialize in cardiac electrophysiology and started off with research on the electrophysiological properties of the pulmonary veins in large animal models in Amsterdam with M Janse and JMT De Bakker and in patients in Bordeaux with Michel Haissaguerre. I have been strongly implicated in the development and evaluation of several innovative therapeutic strategies in atrial fibrillation. I has also a keen interest in lethal ventricular arrhythmias, particularly ventricular fibrillation in different patient populations (IVF, J wave syndromes, ischemic VF, and VF in the setting of hypertrophic cardiomyopathy). I am currently leading the first large-scale study on the characterization of human VF dynamics in various patient populations to better understand VF mechanisms and to propose solutions to detect and prevent patients at risk of SCD.

Lately, in 2010, I was part of the team involved in the creation of the research institute Liryc (Electrophysiology and Heart Modeling Institute) of which I has been the Deputy Director since 2013, bringing me new administrative and scientific responsibilities. More recently, I have taken up the role of Director of the Liryc fundraising campaign in order to improve innovation, inform people and raise their awareness about cardiac electrical disease.